Literature DB >> 18821360

Flanking-sequence exponential anchored-polymerase chain reaction amplification: a sensitive and highly specific method for detecting retroviral integrant-host-junction sequences.

M A Pule1, A Rousseau, J Vera, H E Heslop, M K Brenner, E F Vanin.   

Abstract

BACKGROUND: Retroviral vectors are regularly used to transduce stem cells and their derivatives for experimental and therapeutic purposes. Because these vectors integrate semi-randomly into the cellular genome, analysis of integranated retroviral DNA/host cell DNA junctions (IHJ) facilitates clonality studies of engrafted cells, allowing their differentiation, survival and fate to be tracked. In the case of any adverse events, IHJ analysis can allow the identification of potentially oncogenic integration sites. At present, most measures to assess IHJ are complex, insensitive and may be subject to IHJ selection bias inherent to the technology used.
METHODS: We have developed and validated a simple but effective technique for generating libraries of IHJ, which we term flanking-sequence exponential anchored-polymerase chain reaction (FLEA-PCR). Flanking-sequence random anchoring is used as an alternative to restriction enzyme digestion and cassette ligation to allow consistent detection of IHJ and decrease bias.
RESULTS: Individual clones from plasmid libraries can be sequenced and assembled using custom-written software, and FLEA-PCR smears can be analyzed by capillary electrophoresis after digestion with restriction enzymes. DISCUSSION: This approach can readily analyze complex mixtures of IHJ, allowing localization of these sequences to their genomic sites. This approach should simplify analysis of retroviral integration.

Mesh:

Substances:

Year:  2008        PMID: 18821360      PMCID: PMC2749733          DOI: 10.1080/14653240802192636

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  36 in total

1.  Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.

Authors:  M Schmidt; G Hoffmann; M Wissler; N Lemke; A Müssig; H Glimm; D A Williams; S Ragg; C U Hesemann; C von Kalle
Journal:  Hum Gene Ther       Date:  2001-05-01       Impact factor: 5.695

2.  Rapid detection of retroviral vector integration sites in colony-forming human peripheral blood progenitor cells using PCR with arbitrary primers.

Authors:  B Gentner; S Laufs; K Z Nagy; W J Zeller; S Fruehauf
Journal:  Gene Ther       Date:  2003-05       Impact factor: 5.250

3.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Christof von Kalle; Manfred Schmidt; Françoise Le Deist; Nicolas Wulffraat; Elisabeth McIntyre; Isabelle Radford; Jean-Luc Villeval; Christopher C Fraser; Marina Cavazzana-Calvo; Alain Fischer
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

4.  Polyclonal long-term repopulating stem cell clones in a primate model.

Authors:  Manfred Schmidt; Philipp Zickler; Gesa Hoffmann; Sebastian Haas; Manuela Wissler; Arne Muessig; John F Tisdale; Ken Kuramoto; Robert G Andrews; Tong Wu; Hans-Peter Kiem; Cynthia E Dunbar; Christof von Kalle
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

5.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

6.  In vivo footprinting of a muscle specific enhancer by ligation mediated PCR.

Authors:  P R Mueller; B Wold
Journal:  Science       Date:  1989-11-10       Impact factor: 47.728

7.  Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells.

Authors:  Stephanie Laufs; Bernhard Gentner; K Zsuzsanna Nagy; Anna Jauch; Axel Benner; Sonja Naundorf; Klaus Kuehlcke; Bernhard Schiedlmeier; Anthony D Ho; W Jens Zeller; Stefan Fruehauf
Journal:  Blood       Date:  2002-11-07       Impact factor: 22.113

8.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.

Authors:  Salima Hacein-Bey-Abina; Françoise Le Deist; Frédérique Carlier; Cécile Bouneaud; Christophe Hue; Jean-Pierre De Villartay; Adrian J Thrasher; Nicolas Wulffraat; Ricardo Sorensen; Sophie Dupuis-Girod; Alain Fischer; E Graham Davies; Wietse Kuis; Lilly Leiva; Marina Cavazzana-Calvo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

9.  Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.

Authors:  Claudia Rossig; Catherine M Bollard; Jed G Nuchtern; Cliona M Rooney; Malcolm K Brenner
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

10.  T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.

Authors:  D B Kohn; M S Hershfield; D Carbonaro; A Shigeoka; J Brooks; E M Smogorzewska; L W Barsky; R Chan; F Burotto; G Annett; J A Nolta; G Crooks; N Kapoor; M Elder; D Wara; T Bowen; E Madsen; F F Snyder; J Bastian; L Muul; R M Blaese; K Weinberg; R Parkman
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

View more
  6 in total

1.  High efficiency restriction enzyme-free linear amplification-mediated polymerase chain reaction approach for tracking lentiviral integration sites does not abrogate retrieval bias.

Authors:  Chuanfeng Wu; Alexander Jares; Thomas Winkler; Jianjun Xie; Jean-Yves Metais; Cynthia E Dunbar
Journal:  Hum Gene Ther       Date:  2012-10-26       Impact factor: 5.695

Review 2.  Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity.

Authors:  Chuanfeng Wu; Cynthia E Dunbar
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

3.  Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

Authors:  Helen E Heslop; Karen S Slobod; Martin A Pule; Gregory A Hale; Alexandra Rousseau; Colton A Smith; Catherine M Bollard; Hao Liu; Meng-Fen Wu; Richard J Rochester; Persis J Amrolia; Julia L Hurwitz; Malcolm K Brenner; Cliona M Rooney
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

4.  Clonal Dynamics In Vivo of Virus Integration Sites of T Cells Expressing a Safety Switch.

Authors:  Edmund C Chang; Hao Liu; John A West; Xiaoou Zhou; Olga Dakhova; David A Wheeler; Helen E Heslop; Malcolm K Brenner; Gianpietro Dotti
Journal:  Mol Ther       Date:  2015-12-07       Impact factor: 11.454

5.  Genomic DNA transposition induced by human PGBD5.

Authors:  Anton G Henssen; Elizabeth Henaff; Eileen Jiang; Amy R Eisenberg; Julianne R Carson; Camila M Villasante; Mondira Ray; Eric Still; Melissa Burns; Jorge Gandara; Cedric Feschotte; Christopher E Mason; Alex Kentsis
Journal:  Elife       Date:  2015-09-25       Impact factor: 8.140

6.  Impact of next-generation sequencing error on analysis of barcoded plasmid libraries of known complexity and sequence.

Authors:  Claire T Deakin; Jeffrey J Deakin; Samantha L Ginn; Paul Young; David Humphreys; Catherine M Suter; Ian E Alexander; Claus V Hallwirth
Journal:  Nucleic Acids Res       Date:  2014-07-10       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.